Clinical Trial Update: [18F]MC225-PET in Neurodegenerative Disease [Phase 1, Phase 2]

View source ↗

Summary

Early-phase trial update for [18F]MC225-PET imaging in neurodegenerative diseases, including Alzheimer’s disease and related conditions (Phase 1 and Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Neurodegenerative Diseases
• Parkinson Disease

Drugs mentioned

• [18F]MC225-PET

Snippet

Sponsor: University Medical Center Groningen | Conditions: Neurodegenerative Diseases, Alzheimer Disease | Phase 1, Phase 2 | Status: UNKNOWN